demonstrated that mitochondrial PKM2 plays a vital role in the ROS adaptation of cancer cells, which implicates the HSP90-PKM2-Bcl2 axis as a potential target for therapeutic intervention in gliomas (19). This evidence concerns the gene PKM and glioma.